AIxCrypto Holdings Sells Marizyme Notes for $100K Cash, Future Royalties, and 4.99% Equity

summarizeSummary

AIxCrypto Holdings, facing a going concern warning, has sold its significant debt and co-development notes related to Marizyme, Inc. for a minimal upfront cash payment and speculative future consideration.

check_boxKey Events · Financing and Capital Events · AIXC

• Asset Disposition

  AIxCrypto Holdings sold its 'Note Package' related to Marizyme, Inc., which included a secured promissory note with an outstanding principal of approximately $4,771,142 and a co-development note with a $1,750,000 funding amount.

• Consideration Received

  The company received $100,000 in immediate cash, future royalty payments capped at $5,671,142 (contingent on cumulative net revenue exceeding $20 million), and a 4.99% equity interest in a new entity (CABG SPV) formed to acquire Marizyme's assets.

• Financial Context

  This transaction occurs shortly after the company reported a significant Q1 net loss and a 'going concern' warning in its May 11, 2026 10-Q filing, highlighting its urgent need for capital.

auto_awesomeAnalysis · AIXC · Crypto Assets

This transaction represents a significant disposition of assets by AIxCrypto Holdings, occurring under challenging financial circumstances. The immediate cash infusion of $100,000 is minimal compared to the face value of the notes sold (over $6.5 million) and the company's reported cash burn and going concern warning. While the company retains potential future upside through royalties and a minority equity stake, these are highly contingent and speculative, offering little immediate relief to its liquidity issues. This suggests a distressed sale, reflecting the company's urgent need for capital and potentially a significant write-down of the asset's value.